Skip to main content

MoneyWorks4Me

Windlas Biotech informs about disclosure

21 Mar 2023 Evaluate
Windlas Biotech has informed that the Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for ICICI Prudential Mutual Fund.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1876.70
Dr. Reddys Labs. 1381.30
Cipla 1403.70
Lupin 2016.95
Zydus Lifesciences 1195.35
View more..